|

Parkinson's Disease Clinical Trials in Austin, TX

11 recruiting studies within 50 miles

Phase
Trial Phase Dist.
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's DiseasePhase 2<1 mi
A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's DiseasePhase 1<1 mi
A Study of LY4006896 in Healthy Participants and Participants With Parkinson's DiseasePhase 1<1 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 217 mi
A Phase 2a Multicenter Clinical Trial of TB006 in Participants With Parkinson's DiseasePhase 217 mi
To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor ComplicationsPhase 317 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 317 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/317 mi
A Study of Buntanetap in Participants With PDPhase 2/317 mi
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease—26 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 426 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.